What has not been established is that liposomal glutathione consistently provides: Greater cellular uptake than S-acetyl glutathione in humans More direct delivery to target tissues Faster or more clinically meaningful effects Better symptom, disease or longevity outcomes No robust human head-to-head trial has established a universal winner
Robert Popovian joining me from LA, a pharmacist, economist and Chief Science Policy Officer at the Global Healthy Living Foundation
Post-marketing surveillance is still ongoing What we do know from available research and patient reports: Musculoskeletal side effects (which include muscle cramps) were reported in clinical trials, though at lower rates than gastrointestinal effects Patient forums and post-marketing reports suggest cramping occurs in some patients, particularly during the early weeks of treatment The side effect may be dose-related, with potentially higher incidence at higher doses What patients tend to report about the cramping timeline: Experiences vary widely, but patients in online communities and support groups often describe a pattern where: Cramping tends to first appear within the first 1-2 weeks of starting treatment Many find cramps feel most noticeable around weeks 2-3 A gradual improvement is commonly reported around weeks 4-6 By weeks 8-12, many (though not all) patients report their cramping has significantly improved or resolved Keep in mind that your experience may differ considerably from these general observations
Our providers evaluate your health history, goals, and clinical presentation to determine whether peptide therapy may be appropriate
Research has shown that Vitamin B12 has neuroprotective qualities that may help in safeguarding cognitive function
